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Background: The increase in fructose ingestion has been linked to overdrive of sympathetic activity and
hypertension associated with the metabolic syndrome. The premotor neurons for generation of sympathetic
vasomotor activity reside in the rostral ventrolateral medulla (RVLM). Activation of RVLM results in
sympathoexcitation and hypertension. Neurons in the central nervous system are able to utilize fructose as a
carbon source of ATP production. We examined in this study whether fructose affects ATP content in RVLM and its
significance in the increase in central sympathetic outflow and hypertension induced by the high fructose diet
(HFD).
Results: In normotensive rats fed with high fructose diet (HFD) for 12 weeks, there was a significant increase in
tissue ATP content in RVLM, accompanied by the increases in the sympathetic vasomotor activity and blood
pressure. These changes were blunted by intracisternal infusion of an ATP synthase inhibitor, oligomycin, to the
HFD-fed animals. In the catecholaminergic-containing N2a cells, fructose dose-dependently upregulated the
expressions of glucose transporter 2 and 5 (GluT2, 5) and the rate-limiting enzyme of fructolysis, ketohexokinase
(KHK), leading to the increases in pyruvate and ATP production, as well as the release of the neurotransmitter,
dopamine. These cellular events were significantly prevented after the gene knocking down by lentiviral
transfection of small hairpin RNA against KHK.
Conclusion: These results suggest that increases in ATP content in RVLM may be engaged in the augmented
sympathetic vasomotor activity and hypertension associated with the metabolic syndrome induced by the HFD. At
cellular level, the increase in pyruvate levels via fructolysis is involved in the fructose-induced ATP production and
the release of neurotransmitter.
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The shift of our eating habit to a Western style and con-
sumption of food rich in fatty acid and fructose increase
the risks of developing obesity, insulin resistance, meta-
bolic syndrome and diabetes [1-3]. Large populations of
patients with obese and metabolic syndrome manifest
hypertension [4]. Accumulating evidence suggests that
high fructose diet (HFD) leads to the development of
human metabolic syndrome with complications of hyper-
tension, hyperglycemia, hypertriglyceridemia and insulin
resistance [2-5]. The increase in fructose uptake has been
linked to overdrive of sympathetic activity [6,7], although
the underlying mechanism is not fully understood.
Neurons depends on aerobic metabolism of glucose
for supply of adenosine-5’-triphosphate (ATP). Fructose,
an isomer of glucose in structure, is therefore not an or-
dinary fuel to neuron. However, fructose is able to gener-
ate pyruvate which enters the citric acid cycle as acetyl
coenzyme A under aerobic conditions [8,9]. The acetyl co-
enzyme A can then produce energy via the mitochondrial
respiratory chain. The metabolic pathway that converts
fructose into pyruvate is known as fructolysis. The rate-
limiting enzyme of fructolysis is ketohexokinase (KHK)
which phosphorylates and converts fructose to fructose-
1-phosphate for pyruvate generation. Genes that re-
quired for fructose metabolism are expressed in the
neurons [10], indicating neurons in the brain are able to
utilize fructose as a carbon source of ATP production.
In hippocampal region, it was reported that energy
generated via fructolysis sustains neuronal integrity in
the absence of glucose [11,12].
The rostral ventrolateral medulla (RVLM) contains pre-
motor neurons for generation of supraspinal sympathoex-
citatory outflow [13,14], and therefore is an important
neural substrate for tonic regulation of sympathetic nerve
activity and cardiovascular functions [14]. It is well estab-
lished that increases in neuronal activity in RVLM and the
release of neurotransmitters and neuromodulators from
the RVLM projecting neurons at sympathetic pregangli-
onic neurons in the spinal cord are the major source of
the augmented sympathetic nervous system associated
with hypertension [15,16].
In the present study, we examined whether fructose
serves as an energy substrate in the RVLM and the signifi-
cance of alterations in ATP content at RVLM in pathogen-
esis of the metabolic syndrome-associated hypertension.
In an in vivo animal model of metabolic syndrome in-
duced by the HFD, we found that an increase in tissue
ATP content in RVLM contributed to the augmented
sympathetic vasomotor activity and the increase in blood
pressure. We further examined the molecular mechanism
underlying high fructose-promoted ATP production and
regulation of cellular functions by the use of an in vitro
Neuro 2A (N2a) cell line. We found that fructoseupregulated glucose transporter 2 and 5 (GluT2, 5) and
KHK expressions, leading to an increase in ATP produc-
tion and the release of the neurotransmitter dopamine
from the N2a cells. These results suggest that increases in
ATP content in RVLM is engaged in the augmented sym-
pathetic vasomotor activity and hypertension associated
with metabolic syndrome induced by the HFD. At cellular




Male, adult Wistar Kyoto (WKY) rats were purchased
from the Experimental Animal Center, National Science
Council, Taiwan. Animals were allowed to acclimatize in a
temperature- (22 ± 1°C) and light- (12:12 light–dark cycle,
light on from 0:800) controlled room in an AAALAC
certified animal facility for at least 14 days before the
experiments. All experiments were carried out in ac-
cordance to the guidelines for animal experimentation
endorsed by our Institutional Animal Care and use
committee. Animals were randomly divided into the
normal diet (ND) and high fructose diet (HFD) groups.
In the HFD group, animals received 60% fructose
(TD.89247, Harlan Laboratories, Indianapolis, IN, USA)
as sole food source. The ND animals received regular
chow (Purina, St. Louis, MO, USA). Both food and
water were provided ad libitum. Body weight, as well as
food and water intake of animals were measured and
recorded twice a week.
Measurement of blood pressure
Systemic arterial pressure (SAP) was measured non-
invasively under conscious condition using the tail-cuff
plethysmography (BP-2000, Visitech, Apex, NC, USA).
Animals were trained for 1 week in a pre-warmed tail-cuff
device to accustom the procedure, followed by measure-
ments of SAP twice per week. During each measurement,
SAP was recorded for 30 min between 13:00 and 15:00;
and data were collected for at least 12 weeks. In each
measurement, 10 readings were collected and the mean
value of all readings was used for the SAP.
Power spectral analysis of SAP signals
Power spectral analysis of SAP signals was performed in
animals with sodium pentobarbital (50 mg⋅kg-1, i.p.)
anesthesia. SAP signal was monitored for 30 min between
13:00 and 15:00 by femoral artery cannulation. Power
spectral analysis of SAP signals was performed by fast
Fourier transform. We focused on the low frequency (LF,
0.25-0.8 Hz) component of SAP spectrum, as it takes
origin from the RVLM [17-19] and reflect the prevalence
of sympathetic nerve activity to the vessels.
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To obtain samples for biochemical and molecular ana-
lyses, the brain stem was rapidly removed and placed on
ice. Tissues on both sides of the ventrolateral part of
medulla oblongata, at the level of RVLM (0.5 to 1.5 mm
rostral to the obex) were collected by micropunches
made with a stainless steel bore (1 mm ID) [17,19]. The
collected tissues were stored immediately in liquid nitro-
gen for further analyses.
Total protein isolation
Tissue samples from RVLM were homogenized with a
Dounce grinder with a tight pestle in ice-cold lysis buffer
(15 mM HEPES, pH 7.2, 60 mM KCl, 10 mM NaCl,
15 mM MgCl2, 250 mM Sucrose, 1 mM EGTA, 5 mM
EDTA, 1 mM PMSF, 2 mM NaF, 4 mM Na3VO4). A
mixture of leupeptin (8 μg/mL), aprotinin (10 μg/mL),
phenylmethylsulfonyl fluoride (20 μg/mL) and trypsin
inhibitor (10 μg/mL) was included in the isolation buffer
to prevent protein degradation. The homogenate was cen-
trifuged at 13,500 rpm for 15 minutes, and the supernatant
was collected for protein analysis. The concentration of
the total protein extracted was estimated by the method
of Bradford with a protein assay kit (Bio-Rad, Hercules,
CA, USA).
Measurement of intracellular ATP concentration
Tissue ATP content was determined by ATP colorimetric
assay kit (Biovision, Milpitas, CA, USA). Total protein
samples from RVLM were centrifuged at 13500 rpm for
15 min, and 10 μl supernatant was incubated with ATP re-
action mixture for 30 min. The ATP levels were detected
at 570 nm using a microplate reader (Thermo Fisher Sci-
entific Inc., Waltham, MA, USA). To determine cellular
ATP level in the N2a cells, samples were collected in a
lysis buffer (Thermo Fisher Scientific Inc.) and centrifuged
at 13500 rpm for 15 min. Supernatant (10 μl) was incu-
bated with ATP reaction mixture for 30 min and detected
by the same procedures. ATP levels were normalized to
the protein concentration of the samples. Protein con-
centrations were determined by the Bradford analysis.
All experiments were repeated in quadruplicates.
Measurement of intracellular pyruvate concentration
Cellular pyruvate concentration was determined by the
pyruvate assay kit (Biovision). In brief, 50 μg lysate from
each sample was incubated with pyruvate reaction mixture
in a light-proof condition for 30 min. Pyruvate level was
detected at 570 nm using a microplate reader (Thermo
Fisher Scientific Inc.). Pyruvate concentration was normal-
ized to the protein concentration of the samples. Protein
concentrations were determined by the Bradford analysis.
Each assay was performed in quadruplicates.Measurement of tissue level of the reactive oxygen
species
Levels of reactive oxygen species (ROS) were measured by
flow cytometry using the fluorescence dye dihydroethi-
dium (DHE) for detection of the ROS. Tissue from RVLM
was rinsed, cut into small pieces and sieved by a strainer
(cut-off size of 100 μm). Separated cells were fixed with
4% paraformaldehyde for 10 min at room temperature,
followed by incubation with DHE (5 μM, 0.15% DMSO) in
a light proof condition at the room temperature. The level
of cellular ROS was analyzed with Gallios™ (Beckman, CA,
USA) flow cytometer. Each determination is based on
mean fluorescence intensity of 5,000 cells.
Western blot analysis
Proteins were separated by 10-12% SDS-PAGE and trans-
ferred onto PVDF membrane (Immobilon-P membrane;
Millipore; Bedford, MA, USA). Membranes were incubated
with specific antibodies, followed by washing and incuba-
tion with a horseradish peroxidase-conjugated secondary
antibody. Specific antibody-antigen complex was detected
using an enhanced chemiluminescence Western Blot detec-
tion system (Thermo Fisher Scientific Inc.). The amount of
detected proteins was quantified by ImageJ software (NIH,
Bethesda, MD, USA), and was expressed as the ratio to β-
actin protein. Each assay was performed in quadruplicates.
Intracisternal infusion of the test agent
After anesthetized with sodium pentobarbital (50 mg/kg,
IP), a midline dorsal neck incision was made, and the
dura mater between the foramen magnum and C1 lam-
ina was exposed following dissection of the overlying
muscles. The dura was perforated with a 22-gauge steel
needle. After observation of leakage of cerebrospinal
fluid (CSF) from this hole, a PE-10 catheter (Clay Adams,
Sparks, MD, USA) was advanced for 3 mm into the cis-
terna magna. The infusion catheter was sealed to the
dura with tissue glue and the incision was closed with
layered sutures. The outer end of the catheter was con-
nected to an osmotic minipump (Alzet 1002; Durect
Co., Cupertino, CA, USA), which was placed under the
skin in the neck region [20,21]. Intracisternal (IC) infu-
sion of oligomycin (70 fmol/μl/day) was carried out for
14 days. Infusion dose of oligomycin was determined in
our pilot study. Control infusion of artificial CSF (aCSF)
served as the volume and vehicle control. All animals
received intramuscular injection of procaine penicillin
(1,000 IU) postoperatively, and only those that showed
progressive weight gain after the operation were used in
the subsequent experiments.
Cell culture
N2a cells was originally obtained from American Type
Culture Collection (ATCC, Manassas, VA, USA) and
Wu et al. Journal of Biomedical Science 2014, 21:8 Page 4 of 14
http://www.jbiomedsci.com/content/21/1/8was maintained in Eagle’s minimal essential medium
(MEM; Invitrogen, Carlsbad, CA, USA) supplemented
with 10% FBS (Invitrogen) plus 1% penicillin/streptomycin
(Invitrogen) in an incubation chamber with 5% CO2 and
95% air at 37°C. One day before fructose application, cells
were seeded onto a 10-cm dish at a density of 1 × 106 cells
per well. Different concentrations of fructose (0, 12.5, 25,
or 50 μM) were applied to MEM solution. Following fruc-
tose application, the cells were incubated for 72 h before
various analyses. MEM solution was replaced every two
days to stable nutrition supply.
MTS assays for cell viability
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay (Promega,
Madison, WI, USA) was used to quantify cell viability.
Cells (100 μL, 1 × 105 cells/ml) were seeded into a 96-well
flat-bottomed plate at 37°C with 5% CO2. At 72 h after
fructose treatment, the cells were washed with PBS for
three times and replaced with fresh medium (100 μL).
MTS (20 μL) reagents were added to each well, and the
plate was incubated for 4 h under dark. Absorbance was
recorded at 490 nm using a microplate reader (Thermo
Fisher Scientific Inc.). Blank wells with no reagent were
measured for luminescence and were deducted from the
values of the experimental wells. Values of viability of the
treated-cells were expressed as a percentage of that from
corresponding control cells. All experiments were re-
peated in quadruplicates.
Measurement of dopamine concentration
Dopamine level was measured by enzyme-linked immuno-
sorbent assay kit (LDN®, Nordhorn, Germany). Medium of
N2a cells was collected at 72 h after exposure to fructose
alone or with additional drug treatment. 50 μl samples or
standard were incubated with Detection Reagent A for
60 min at 37°C, followed by incubation with Detection Re-
agent B for 30 min at 37°C under light-proof condition.
After 15–25 min substrate incubation, the reaction was
stopped by Stop Solution. Dopamine level was detected
at 450 nm using a microplate reader (Thermo Fisher
Scientific Inc.) and was expressed as pg/ml of medium.
All experiments were repeated in quadruplicates.
Glucose uptake assay
A non-radioactive 2-deoxyglucose (2DG, 4 mmol/L)
(Biovision) was incubated with N2a cells for 30 min
after overnight starvation. Cells were then collected for
homogenization and detection of intracellular metabolite,
2-DG6-phosphate (2-DG6P). Cell lysate was reacted with
reagent A followed by reagent B. After incubation, the
level of 2-DG6P was analyzed by the colorimetric enzym-
atic methods according to the manufacturer’s instructions.
Each assay was performed in quadruplicates.Gene silencing of Ketohexokinase
The short hairpin RNA (shRNA) oligonucleotides for
silencing KHK expression in N2a cell was purchased
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA,
USA). N2a cells were seeded into a 12-well Plate 24 h
prior to lentiviral infection. 1 mL medium (with serum
and antibiotics) was added and incubated with cells
overnight. On the day of infection, the culture media
was removed from the wells and replaced with 1 mL of
Polybrene/media mixture. Lentiviral particles (1 × 105
plague forming units/1 mL) were thawed at room
temperature and mix gently and incubated with cells
overnight. This was followed by removal of the culture
medium and replaced with 1 mL of complete medium
without Polybrene overnight. To select stable clones
expressing the shRNA, cells were split in 1:3 and incu-
bated continuously for 24–48 h in the medium. Stable
clones expressing the shRNA were selected by Puro-
mycin dihydrochloride, and were followed by replacing
the medium with fresh puromycin-containing medium
every 3–4 days until resistant colonies were identified.
These colonies were expanded and assayed for stable
shRNA expression. Cells were transfected in parallel
with control shRNA lentiviral particles (Santa Cruz
Biotechnology) as negative controls.
Immunofluorescence staining
The cell was fixed 15 min in the 4% paraformaldehyde in
0.1 M phosphate buffered saline (PBS, pH 7.4). After
washed with PBS and permeabilization with 0.1% Triton
X 100 in 0.1% sodium citrate, the cell was incubated with
the anti-KHK antibody at room temperature for 2 hour
and then rinsed 3 times in PBS. After incubation in fluor-
escence conjugated IgG (Vector Laboratories, Burlingame,
CA, USA) for 1 hour, the cells were rinsed with PBS.
4’,6-diamidino-2-phenylindole (DAPI) was employed to
identify the morphology of cell nuclei. The expression
and distribution of fluorescence signals were detected
under an Olympus Fluoview 1000 laser confocal micro-
scope (Tokyo, Japan) equipped with a krypton/argon
laser.
RNA isolation and reverse transcription real-time
polymerase chain reaction
To detect KHK mRNA expressions, total RNA from the
treated cells were isolated with TRIzol reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s
protocol. All RNAs isolated were quantified by spectro-
photometry and the optical density 260/280 nm ratio
was determined. Reverse transcriptase (RT) reaction
was performed using a SuperScript Preamplification
System (Invitrogen) for the first-strand cDNA synthesis.
Real-time PCR analysis was performed by amplification
of cDNA using a LightCycler® 480 instrument (Roche
Figure 1 High fructose diet induces increases in blood pressure
and sympathetic vasomotor activity in rats. The systemic arterial
pressure (SAP, A) and power density of low frequency (LF, B)
component of the SAP signals, our experimental index of the
sympathetic vasomotor activity, measured in week 12 in animals
subjected to the normal diet (ND) or high fructose diet (HFD). Values
are mean ± SEM (n = 8 to 12 animals in each experimental group).
*P < 0.05, **P < 0.01 versus ND group in the student t test.
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in real-time PCR amplification were designed using
Roche LightCycler probe design software 2.0 based on
sequence information from the NCBI database, and
were synthesized by Genemed Biotechnologies (San
Francisco, CA, USA). The primer pairs for amplification
of KHK cDNA are: forward (5′- GATACCCCTTGCTCT
TGCTG-3′) and reverse (5′- TGCAGCATCTTCACCTG
TTC-3′); β-actin cDNA are: forward (5′- GCTGAGAGG
GAAATCGT −3′) and reverse (5′- CGTCAGGCAGCT
CATAG −3′).
PCR reaction for each sample was carried out in dupli-
cates for all the cDNA and for the β-actin control. The
amplification protocol for cDNA on the LightCycler®
480 was a 10 min denaturation step at 95°C for poly-
merase activation, a “touch down” PCR step of 10 cycles
consisting of 10 s at 95°C, 10 s at 65°C, and 30 s at 72°C,
followed by 40 cycles consisting of 10 s at 95°C, 10 s at
55°C, and 30 s at 72°C. After slow heating (0.1°C per
second) the amplified product from 65°C to 95°C to
generate a melting temperature curve, which serves as a
specificity control, the PCR samples were cooled to 4°C.
Fluorescence signals from the amplified products were
quantitatively assessed using the LightCycler® 480
software program. Second derivative maximum mode
is chosen with baseline adjustment set in the arith-
metic mode. The relative change in mRNA expression
was determined by the fold-change analysis, in which
Fold change = 2−[ΔΔCt], where ΔΔCt = [(Cttarget mRNA −
Ctβ-actin) treatment − (Cttarget mRNA −Ctβ-actin)control]. Note
that Ct value was the cycle number at which fluorescence
signal crosses the threshold.
Statistic analysis
Data are expressed as means ± SEM. The statistical soft-
ware GraphPad Prism (La Jolla, CA, USA) was used for
data analysis. For biochemical experiments that involved
two groups of samples, Student’s unpaired t test was
used. For biochemical experiments that involved multiple
groups, one-way or two-way analysis of variance with re-
peated measures were used to assess group means. This
was followed by the Tukey’s multiple range test for post
hoc assessment of individual means. *P < 0.05 was consid-
ered statistically significant.
Results
High fructose diet increases blood pressure and
sympathetic vasomotor tone
In comparison to the ND group, animals received HFD
for 12 weeks induced a significant increase in SAP
(Figure 1A), accompanied by an increase in the sympa-
thetic vasomotor activity reflected by the increase in
power density of the LF component of SAP spectrum
(Figures 1B). In addition, animals subject to the 12-weeks HFD developed characteristics of metabolic syn-
drome (Table 1). Feeding animals the HFD for 12 weeks,
on the other hand, did not affect daily food intake (ND
vs. HFD, 35.2 ± 1.23 g vs. 40.8 ± 2.43 g, n = 32, P > 0.05)
or the body weight (ND vs. HFD, 340.3 ± 6.09 g vs.
341.8 ± 6.78 g, n = 32, P > 0.05) measured at the age of
17-weeks old.
High fructose diet increases tissue ATP content, KHK and
glucose transporter expression in RVLM
At the end of 12-weeks HFD, there was a significant in-
crease in tissue ATP content in RVLM (Figure 2A). This is
associated with upregulations in protein expressions of the
rate-limiting enzyme of fructolysis, KHK, (Figure 2B) and
the glucose transporters, GluT2 and GluT5, (Figure 2C) in
the same brain region. For the negative control, we found
that tissue ATP content in the hippocampus, a brain area
that is not directly involved in the autonomic regulation of
Table 1 Metabolic parameters evaluated in week 12 after
subjected the animals to the ND or HFD
ND (n = 12) HFD (n = 12)
Fasting blood sugar (mg/dL) 85.83 ± 1.88 93.08 ± 2.45*
Fasting blood insulin (pmol/L) 49.95 ± 5.98 168.70 ± 45.72*
HOMA-IR 0.92 ± 0.11 2.63 ± 0.59*
Fasting blood triglyceride (mmol/L) 113.40 ± 2.04 146.30 ± 12.81*
Waistline (cm) 15.98 ± 0.20 15.81 ± 0.21
Data are means ± SEM. *P < 0.05 vs. ND rats.
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Figure S1).High fructose diet upregulates protein expression of the
mitochondrial electron transport chain enzyme complex
in RVLM
To delineate whether the increase in tissue ATP level in
RVLM resultant from the increase of oxidative phosphor-
ylation, expression of mitochondrial respiratory chain pro-
teins were determined. Compared with the ND-fed rats,
the expression of mitochondrial respiratory complexes
proteins, including Complexes I, II, and IV, were markedly
increased in RVLM of the HFD-fed rats (Figure 3). ProteinFigure 2 High fructose diet increases tissue ATP content and upregul
Tissue levels of ATP (A) and representative gels (inset) or densitometric ana
transporter 2 or 5 (GluT2 or GluT5) (C and D) in RVLM detected in week 12
each experimental group). *P < 0.05, **P < 0.01, ***P < 0.001 versus ND grouexpressions of Complexes III and V in RVLM, on the
other hand, were not affected by the HFD. The HFD also
did not affect tissue level of the reactive oxygen species
(ROS) (Additional file 2: Figure S2).
Suppression of heightened ATP content in RVLM
attenuates HFD-induced hypertension
To establish a causal role of ATP increment at RVLM in
hypertension induced by the HFD, an ATP synthase in-
hibitor, oligomycin (70 fmol/μl/day), was infused into the
cisterna magna from week 10 to 12 after the HFD. In
comparison to aCSF infusion, IC infusion of oligomycin
significantly blunted the pressor response in the HFD-fed
animals (Figure 4A). The same treatment, however, did
not affect the SAP in the ND-fed animals. IC infusion of
oligomycin for 2 weeks prevented the increase in tissue
level of ATP in RVLM of the HFD-fed animals. The same
treatment also slightly suppressed ATP content in RVLM
of the ND-fed animals (Figure 4B).
Fructose increases ATP production and dopamine release
from the catecholamine-containing N2a cells
The N2a cell is a mouse neural crest-derived cell line
that has been extensively used to study functions of the
catecholamine-containing neurons [22]. This cell lineates ketohexokinase and glucose transporter expression in RVLM.
lysis of protein level of ketohexokinase (KHK) (B) or glucose
after the ND or HFD. Values are mean ± SEM (n = 8 to 12 animals in
p in the student t test.
Figure 3 High fructose diet induces upregulation of the mitochondrial respiratory chain enzymes in RVLM. Representative gels (inset)
and densitometric analysis of results from Western blot showing changes in expression of mitochondrial respiratory complex (Mt cpx) I to V
(A to E) in week 12 after the ND or HFD. Values are mean ± SEM (n = 8 to 12 animals in each experimental group). *P < 0.05, **P < 0.01 versus ND
group in the student t test.
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model to investigate mechanisms underlying the fructose-
induced increase in ATP content and the effect of fructose
on neuronal function, reflected by the release of neuro-
transmitter, dopamine. Incubation of the N2a cells with
different concentrations of fructose (0, 12.5, 25, or 50 μM)
in the culture medium for 72 h resulted in a dose-related
increase in cellular ATP content (Figure 5A). Results from
ELISA assay further showed that fructose caused a dose-
dependent increase in dopamine content measured in the
culture medium (Figure 5B). Under these dosing ranges,
fructose had no notable effect on viability of the N2a cells
(Figure 5C).Fructose upregulates ketohexokinase and glucose
transporter expression as well as increases cellular
pyruvate level in N2a cells
Fructose is capable of generating pyruvate via fructolysis
to be further used for energy generation. KHK is the
rate-limiting enzyme in the fructolytic pathway. In the
N2a cells we found that pyruvate levels were increased
(Figure 6A) and KHK expression were significantly upreg-
ulated by the fructose in the culture medium (Figure 6B).
The same treatments also upregulated protein expression
of GluT2 and GluT5 (Figure 6C and D). In contrast, fruc-
tose had no effect on uptake of glucose to the N2a cells
(Figure 6D).
Figure 4 Reversal by oligomycin on the HFD-induced pressor
response and the increase in ATP content in RVLM. The SAP
(A) and tissue ATP content in RVLM (B) examined in week 12 after ND or
HFD alone or with additional intracisternal infusion of oligomycin (70 fmol/
μl/day for 14 days) from week 10 to 12. Values aremean± SEM (n = 5 to 8
animals in each experimental group). *P<0.05 versus NDgroup and
#P<0.05 versus HFDgroup in the post hoc Tukey’smultiple range analysis.
Figure 5 Fructose increases cellular ATP levels and the release
of dopamine from the Neuro 2a cells. The cellular ATP contents
(A), levels of dopamine in culture medium (B) and cell viability (C) of the
N2a cells determined at 72 hours after exposure to different concentrations
of fructose (0, 12.5, 25, or 50 μM). Values are mean ± SEM of quadruplicate
analyses. *P<0.05, **P<0.01 versus control (0 μM fructose) group in the
post hoc Tukey’s multiple range analysis.
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fructose-induced pyruvate and ATP production as well as
dopamine release
To further delineate a causal relationship of fructose-
induced increases in KHK expression on ATP produc-
tion and dopamine release, lentiviral transfection of
KHK shRNA (0.5 MOI) was performed to knocking
down KHK expression in the N2a cells. In comparison
with lentiviral transfection of control shRNA, expres-
sion of KHK mRNA in the N2a cells was effectively
suppressed at 72 h following the shRNA transfection
(Figures 7A and B). Furthermore, when the KHK gene-
silencing N2a cells was subjected to evaluation of pyru-
vate and ATP production at 72 h after incubation with
fructose, the dose-related increases in their production
by fructose were also significantly inhibited (Figures 7C
and D), alongside a reversal of dopamine release (Figure 7E).
Transfection of control shRNA had no effect on the
fructose-induced increases in pyruvate and ATP pro-
duction, or the dopamine release from the N2a cells.Discussion
The most significant finding of this study was an increase
in tissue ATP content in RVLM and its engagement in the
augmented sympathetic vasomotor activity and hyperten-
sion induced by the HFD. To our knowledge this is the
first demonstration to link tissue ATP content in brain
cardiovascular neurons to the altered central autonomic
function in the setting of hypertension associated meta-
bolic syndrome. At cellular level, our data from the N2a
Figure 6 Fructose upregulates the expression of ketohexokinase and glucose transporters in the N2A cells. Cellular levels of pyruvate
(A) and 2-deoxyglucose 6-phosphate (2-DG6P) (E), or representative gels (inset) and densitometric analysis of results from Western blot showing
changes in expression of KHK (B), GluT2 (C) or GluT5 (D), examined at 72 hours after the administration of different concentrations of fructose
(0, 12.5, 25, or 50 μM) to the N2a cells. Values are mean ± SEM of quadruplicate analyses. *P < 0.05, **P < 0.01 versus control (0 μM fructose) group
in the post hoc Tukey’s multiple range test.
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creases ATP production via upregulation of the trans-
porters and enzyme that are involved in fructolysis for the
generation of pyruvate. Functionally, the increased ATP
plays an active role in the regulation of cellular phenotype
by increasing the neurotransmitter release.
The metabolic syndrome is closely related to dysfunc-
tion of the autonomic nervous system. In this regard,
patients with the syndrome are observed with an in-
creased sympathetic nerve activity [23,24] and high urine
or plasma catecholamine concentrations [25]. In the HFD-
fed rats, an experimental model of human metabolicsyndrome [26], we found in the current study that cen-
tral sympathetic outflow, reflected by the increases in
power density of the LF component of SAP spectrum
[13], was significantly increased, alongside the pressor
response. These findings extend the previous reports on
the increase in peripheral sympathetic activity [27,28]
and unravel an additional mechanism via activation of
the central sympathetic outflow in manifestation of
sympathetic overactivation and hypertension in the
metabolic syndrome. In obesity-induced hypertension, a
condition often observed in patients with metabolic
syndrome, it was reported that the high blood pressure
Figure 7 KHK gene knockdown prevents the fructose-induced increases in cellular pyruvate and ATP level as well as dopamine release
from the N2a cells. Representative immunofluorescence images showing distribution of KHK in the N2a cells (A) on day 7 after the lentiviral
transfection of small hairpin RNA of KHK (KHK shRNA) or control shRNA; as well as changes in KHK mRNA (B), cellular pyruvate (C) and ATP
contents (D), and dopamine levels in the culture medium (E), detected at 72 hours after the administration of different concentrations of fructose
(0, 12.5, 25, or 50 μM) to the culture medium of the KHK shRNA or control shRNA-transfected N2a cells. Values are mean ± SEM of quadruplicate
analyses. *P < 0.05 versus control (0 μM fructose) group and #P < 0.05 versus CONTROL shRNA group in the post hoc Tukey’s multiple range
tests. WT, wild type N2a cells. 4’,6-diamidino-2-phenylindole (DAPI) was used to identify nucleus in the cultured cells.
Wu et al. Journal of Biomedical Science 2014, 21:8 Page 10 of 14
http://www.jbiomedsci.com/content/21/1/8is related to sympathoexcitation in cardiovascular regula-
tory centers such as hypothalamic nuclei and the RVLM
[29,30]. It is noteworthy that the LF component of the
SAP signals originates from the RVLM [13]. Together
these results suggest the RVLM as a major neural sub-
strate for generation of sympathoexcitation and hyperten-
sion in the metabolic syndrome. Power density of the LF
component of the SAP signals evaluated under anesthetic
condition was comparable to that recorded under the
conscious condition [31].We therefore reason that short
term anesthesia might not affect the cardiovascularperformance, at least the frequency components of the
SAP spectrum. Normotensive rat fed with a HFD is a
well-established rodent model for study of human meta-
bolic syndrome. This model mimics several features, in-
cluding hypertension, insulin resistance, and abnormal
lipid profile, of the western diet-induced metabolic syn-
drome in patients [32,33]. Our results of no different in
the waistline measurement are in consistence to the pub-
lished data in which animals subjected to 60% HFD do not
develop obesity [34]. As such the observations made in
this study are not directly related to the obesity.
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http://www.jbiomedsci.com/content/21/1/8The mechanism linking the metabolic syndrome with
central sympathoexcitation is not fully understood. We
found that tissue ATP content was significantly in-
creased in RVLM of the HFD-fed rats. An active role of
tissue ATP in sympathoexcitation and hypertension in
the metabolic syndrome was further established by the
intervention to partially block ATP production in RVLM
via IC infusion of the ATP synthase inhibitor, oligomycin.
At a dose that only moderately inhibits ATP content in
RVLM of the ND-fed rats, oligomycin prevents the in-
crease in ATP content in RVLM following the HFD.
This treatment also prevents the increase in central
sympathetic outflow and hypertension. The sympathetic
premotor neurons in RVLM are highly sensitive to ATP.
They can be excited in response to exogenous ATP or
ATP receptor agonists [35,36]. Moreover, an increase in
tissue concentration of ATP in the RVLM leads to an in-
crease in activity of the sympathetic premotor neurons,
resulting in the increased central sympathetic drive [37].
Expression of the mitochondrial electron transport chain
enzymes is essential for generation of ATP. Our results
of upregulations of these enzyme complexes imply the
induced increase in ATP content may attributed to the
increase in the machinery of mitochondrial oxidative
phosphorylation in RVLM. The observations that tissue
level of ROS in the RVLM was not affected by the HFD
further suggest a minor role of the radicals in neural
mechanism of hypertension induced by the HFD. This
finding is seemingly disparate to the previous reports
of an active role of ROS in RVLM on neurogenic
hypertension induced by angiotensin II [20] or obesity
[29]. Although reasons behind the discrepancy are not
immediately clear, it is possible that different signals in
the RVLM may have their prevalence in mediating
sympathoexcitation among different animal models of
hypertension.
While the premotor neurons for generation of sympa-
thetic vasomotor activity reside in the RVLM [13,14],
integration of cardiovascular signals in the brain areas,
such as the nucleus tractus solitarii (NTS) and hypo-
thalamic paraventricular nucleus (PVN), are important
for the autonomic regulation of the blood pressure. In
our preliminary experiments, we found that there is no
apparent difference in tissue ATP levels in the NTS or
PVN of the ND versus HFD rats. In addition, in the
hippocampus (a brain area that is not directly related to
autonomic control of the blood pressure) of the HFD
rats, there is no significant increase in tissue ATP content.
Together these results indicate site specificity of the obser-
vations and imply that RVLM neurons are more sensitive
to changes in tissue fructose level, although the involve-
ment of other autonomic nuclei can not be excluded.
Fructose has been strongly linked to the increases
in sympathetic activity associated with the metabolicsyndrome [6,7]. The observations of an active role of
ATP in RVLM on sympathoexcitation in the HFD-fed
rats urged us to delineate cellular mechanisms under-
lying the fructose-induced ATP production. The N2a
cell line has been used as a model for studying the func-
tion of the catecholamine-containing cells [22], of
which the RVLM neurons belong to [13]. We found in
N2a cells that fructose evoked a dose-related increase in
pyruvate and ATP content both of which were blunted
by the gene knocking down of KHK, the rate-limiting
enzyme that converts fructose into pyruvate. Pyruvate
enters the mitochondria where it is converted to Acetyl
CoA for further generation of ATP under aerobic condi-
tion. Together with the observations of a significant up-
regulation of KHK expression in response to fructose,
these results indicate that in N2a cells activation of fructo-
lysis with the subsequent generation of pyruvate may ac-
count for the increase in ATP production in response to
fructose. The significance of KHK in the fructose-induced
metabolic syndrome was demonstrated in a recent study
in which the syndrome was prevented in mice lacking the
KHK isoforms [38]. However, whether the same mechan-
ism is involved in the HFD-induced ATP production in
RVLM and manifest of hypertension await further elucida-
tion. This can be further studied by the lentiviral transfec-
tion of KHK shRNA to knocking down KHK expression
in RVLM.
While fructose shares structure similarity with glucose,
they are metabolized in completely different ways and
utilize different GluT transporters [39-42]. GluT5 is the
primary transporter facilitating the diffusion of fructose
across the cell membrane [40], whereas GluT2 prefers to
transport glucose [41,42]. In addition, recent studies
have shown that GluT2 also exhibits an important role
in the absorption and transport of fructose [41,42]. In
the current study, we found that both GluT2 and GluT5
are upregulated in the N2a cells following fructose ex-
posure. In view that levels of the intermediate metabolite
of glucose, glucose-6-phosphate, in the cells were not af-
fected by high fructose, we reason that the increases in
both GluT2 and GluT5 transporters may contribute to
an increase in absorption and transport to the N2a cells
of fructose, which is in turn metabolized to pyruvate via
fructolytic process. Our results, at the same time, provide
evidence to support the notion that fructose can be uti-
lized by neurons as a carbon source of ATP production.
We provide direct evidence of a functional role of ATP
in the N2a cells to promote neurotransmitter release. Not
only fructose evoked a dose-dependent release of dopa-
mine, manipulations that blocked the fructose-induced
ATP production also blunted dopamine release. It is thus
reasonable to postulate that exaggerated ATP generated
following high fructose exposure may lead to activation of
neurotransmission and the release of the neurotransmitter.
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http://www.jbiomedsci.com/content/21/1/8ATP is known for its role in exocytosis for neurotransmitter
release. ATP supply is indispensable for vesicle mobilization
into the readily releasable pool [43,44]. In addition, follow-
ing exocytosis, the rate of recovery of neurotransmitter re-
lease is also determined by vesicle retrieval from the plasma
membrane, which is dependent on ATP supply [45].
We recognize that fructose may not satisfy the satiety
center in the brain the way glucose does, and that food
intake in the HFD group can be higher than that in the
ND group [46]. This higher caloric intake may contribute
to the harmful metabolic effects other than fructose per se
[47]. In this regard, our data show similar daily food intake
and the body weight in the ND and HFD animals. In
addition, the HFD (3.6 Kcal/g) we used has a comparable
calorie to that of the ND (4.8 Kcal/g). It is thus deemed
unlikely the confounding effect of high caloric intake inFigure 8 Schematic illustrations showing potential mechanisms unde
this scheme, high fructose upregulates both GluT2 and GluT5 expression, r
a greater generation of pyruvate via activation of fructolysis. This high cellu
coenzyme to produce a greater amount of ATP via the mitochondrial resp
neurotransmitter. The shRNA gene silencing of the rate-limiting enzyme, ke
inhibitor, oligomycin, blunts the mitochondrial oxidative phosphorylation tthe HFD group on the induced hypertension. We also
recognize that endothelial dysfunction [48], activation of
proinflammatory cytokines [49,50] and renal oxidative
stress [51] are all engaged in pathogenesis of the metabolic
syndrome and hypertension induced by the HFD.
It is unclear in the current study how fructose reaches
RVLM following a long-term HFD. In this regard, fruc-
tose is capable to cross the blood–brain barrier [52].
The pericytes making close contacts with the cerebral
microvascular endothelial cells are vital for viability and
function of the blood–brain barrier [53]. It was recently
reported [54] that a decline in the number of cerebral
pericytes is responsible for glucose uptake and the
pathological changes in the brain induced by hypergly-
cemia. In the central nervous system, astrocyte-neuron
communication has recently been proposed as a potentialrlying the increase in cellular ATP production by high fructose. In
esulting in an increase in cellular uptake of fructose and subsequently
lar level of pyruvate then enters the citric acid cycle as acetyl
iratory chain complexes, resulting in an increase in the release of
tohexokinase, blocks generation of pyruvate and the ATP synthase
o prevent the high fructose-induced ATP generation.
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http://www.jbiomedsci.com/content/21/1/8mechanism participating in synaptic transmission [55].
Astrocytes are capable of generating and releasing ATP.
Whether the results obtained from the in vitro N2a cells
could be translated to explain the observations in the ani-
mal study, therefore, await further validation. In addition,
the role of astrocytes on ATP production and activation
of sympathetic premotor neurons in RVLM to the HFD
also awaits further investigation.
Conclusion
The present study unveiled a potential novel mechanism
underlying the sympathoexcitation and hypertension
observed following the HFD fed, the increase in ATP
production in the RVLM. We further demonstrated
that, in a catecholaminergic neuronal cell line, fructose
increases pyruvate and ATP production via upregula-
tions of GluT2/5 and KHK, resulting in an increase in
neurotransmitter (e.g., dopamine) release. Given the
roles of GluT2/5 in fructose uptake and KHK in fructo-
lysis, we proposed that, at a cellular level, an increase in
GluT2/5 expression may cause an increase in cellular up-
take of fructose and subsequently a greater generation of
pyruvate via activation of fructolysis. This high cellular
level of pyruvate then enters the citric acid cycle as acetyl
coenzyme to produce a greater amount of ATP via the
mitochondrial respiratory chain complexes, resulting in an
increase in the release of neurotransmitter (Figure 8). This
ATP-dependent increase in neurotransmitter release is
further postulated to be involved in sympathoexcitation
and hypertension induced by the HFD.
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difference between the two groups in the student t test.
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